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Zusammenfassung 
 
 
 
 
Einleitung  
 
Für das Injektionsnarkotikum Propofol (2,6-diisopropylphenol) konnte bereits in 
verschiedenen In-vitro-Modellen von Sauerstoff- und Glukoseentzug ein 
neuroprotektiver Effekt nachgewiesen werden. Im Rahmen dieser Dissertationsschrift 
wurde der neuroprotektive Effekt von Propofol in einem In-vitro-Modell des 
traumatischen Hirnschadens untersucht.  
 
 
Material und Methoden 
 
In dieser laborexperimentellen Studie wurden organotypische hippocampale 
Schnittkulturen von 6-8 Tage alten Mäusejungtieren benutzt. Nach 14-tägiger 
Kultivierung wurden die Schnitte einem fokalem mechanischen Trauma unterzogen 
und anschließend mit verschiedenen Propofolkonzentrationen unter sowohl Normo- 
als auch Hypothermie inkubiert. Nach 72 Stunden wurde das Ausmaß der 
Gewebeschädigung mit Hilfe von Propidiumiodidfärbung unter dem 
Fluoreszenzmikroskop quantitativ erfasst. Propidiumiodid ist ein Farbstoff, welcher 
nur fluoreszent wird, wenn er in geschädigte Zellen über Löcher in der Zellmembran 
eindringt. Innerhalb der Zelle bildet Propidiumiodid fluoreszierende Komplexe mit 
nukleärer DNA.  
 
 
Ergebnisse 
 
Es zeigte sich eine dosisabhängige Reduktion sowohl des totalen als auch des 
sekundären Gewebetraumas nach Inkubation mit Propofol. Der neuroprotektive 
Effekt wurde weiter verstärkt, wenn die Gewebeschnitte nach dem Trauma unter 
Hypothermie bei 32°C zusammen mit Propofol inkubier t wurden.   
 
 
Schlussfolgerung 
 
Bei der kombinierten Anwendung von Propofol und Hypothermie zeigte sich ein 
additiver neuroprotektiver Effekt in diesem In-vitro-Modell des traumatischen 
Hirnschadens.   
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Abstract
Introduction The anaesthetic agent propofol (2,6-
diisopropylphenol) has been shown to be an effective
neuroprotective agent in different in vitro models of brain injury
induced by oxygen and glucose deprivation. We examined its
neuroprotective properties in an in vitro model of traumatic brain
injury.
Methods In this controlled laboratory study organotypic
hippocampal brain-slice cultures were gained from six- to eight-
day-old mice pups. After 14 days in culture, hippocampal brain
slices were subjected to a focal mechanical trauma and
subsequently treated with different molar concentrations of
propofol under both normo- and hypothermic conditions. After
72 hours of incubation, tissue injury assessment was performed
using propidium iodide (PI), a staining agent that becomes
fluorescent only when it enters damaged cells via perforated cell
membranes. Inside the cell, PI forms a fluorescent complex with
nuclear DNA.
Results A dose-dependent reduction of both total and
secondary tissue injury could be observed in the presence of
propofol under both normo- and hypothermic conditions. This
effect was further amplified when the slices were incubated at
32°C after trauma.
Conclusions When used in combination, the dose-dependent
neuroprotective effect of propofol is additive to the
neuroprotective effect of hypothermia in an in vitro model of
traumatic brain injury.
Introduction
Traumatic brain injury (TBI) is a common consequence of traf-
fic-related accidents and incidents at work and at home. The
annual incidence of TBI in the UK is estimated to be approxi-
mately 400 per 100,000 patients per year [1]. The treatment
of patients with traumatic injury to the brain accounts for a con-
siderable proportion of the budget spent annually on health
care and the subsequent costs for rehabilitation, post-hospital
long-term care and disability are a significant burden for the
economy and society. It should be noted that all currently avail-
able therapy approaches for TBI are symptomatic in nature. To
date, no clinically established therapy exists that specifically
counteracts the actual pathological mechanisms leading to
traumatic brain tissue injury.
Propofol (2,6-diisopropylphenol) is a short-acting, intravenous
hypnotic agent widely used for the induction and maintenance
of general anaesthesia in the perioperative setting, for seda-
tion in intensive care unit patients and for short-time interven-
tional procedures. Propofol has been shown to be an effective
neuroprotective agent in certain in vitro models of brain injury
induced by oxygen-glucose deprivation. To this point, the
effects of propofol on the outcome of mechanically induced
brain injury have not been investigated.
We demonstrate that the anaesthetic agent propofol (2,6-
diisopropylphenol) exerts a strong neuroprotective effect in an
in vitro model of TBI and that this effect is further amplified
when propofol is applied under hypothermic conditions.
ANOVA: analysis of variance; DMSO: dimethyl sulfoxide; GABA: gamma-aminobutyric acid; HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid; PI: propidium iodide; SEM: standard error of the mean; TBI: traumatic brain injury.
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Materials and methods
Organotypic hippocampal slice cultures
All experiments were performed in compliance with the local
institutional Ethical Review Committee and have been
approved by the animal protection representative at the Insti-
tute of Animal Research at the RWTH Aachen University Hos-
pital, according to the German animal protection law §4,
Section 3. Unless otherwise stated, all chemicals were
obtained from PAA Laboratories GmbH (Pasching, Austria).
The organotypic hippocampal slice cultures were prepared
from the brains of six to eight-day-old C57/BL6 mice pups
(Charles River Laboratories, Sulzfeld, Germany) as previously
reported [2], with some modifications. Immediately after
extraction, the brain was submerged into ice cold preparation
medium consisting of Gey's balanced salt solution (Sigma
Aldrich, Munich, Germany) containing 5 mg/ml D-(+)-glucose
(Roth, Karlsruhe, Germany) and 0.1% antibiotic/antimycotic
solution (containing penicillin G 10,000 units/ml, streptomycin
sulfate 10 mg/ml and amphotericin B 25 g/ml).
The hippocampi were dissected under stereomicroscopic
supervision, placed on a McIllwain tissue chopper (The Mickle
Laboratory Engineering Co. Ltd., Gomshall, UK) and cut into
400 M thick slices. The slices were then transferred into the
ice cold preparation medium, separated from each other and
placed onto the membrane of a tissue culture insert (MilliCell-
CM, Millipore Corporation, Billerica, MA, USA) that was posi-
tioned inside a 35 mm tissue culture plate (Sarstedt, Newton,
MA, USA). Growth medium containing 50% Eagle minimal
essential medium with Earle's salts, 25% Hank's balanced salt
solution, 25% heat inactivated horse serum, 2 mM L-
glutamine, 5 mg/ml D-glucose, 1% antibiotic/antimycotic solu-
tion and 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer solution (Fluka, Buchs, Switzerland) was
placed underneath the membrane allowing for substrate diffu-
sion. The culture plates containing the membrane inserts with
hippocampal slices on top were incubated at 37°C in a humid-
ified atmosphere of 95% air and 5% carbon dioxide. The
growth medium was exchanged 24 hours after preparation
and every third day thereafter.
Traumatic brain injury
After cultivation over a 14-day period the growth medium was
replaced with experimental medium which differed from the
growth medium with the substitution of horse serum with extra
Eagle minimal essential medium and the addition of 4.5 M
propidium iodide (PI; Sigma Aldrich, Munich, Germany). After
30 minutes of incubation with PI, baseline fluorescence imag-
ing was performed. The TBI was produced using a specially
designed apparatus as previously reported [3]. The construc-
tion of the apparatus was based on previously published
descriptions [4-6]. Under stereomicroscopic supervision a sty-
lus with a diameter of 1.65 mm was positioned 7 mm above
the CA1 region of the hippocampal slices with the aid of a
three-axis micromanipulator and was dropped onto the slice
with constant and reproducible impact energy of 5.26 J. The
drop height, being directly proportional to the impact energy,
was chosen so that the neuronal tissue was not ruptured or
perforated.
Intervention
After traumatising the slices, the medium was exchanged for
experimental medium containing 4.5 M PI. PI was present at
all times until final imaging. The culture plates with the slices
were returned to the incubator with an atmosphere of 95% air/
5% carbon dioxide at 37°C for 72 hours before final fluores-
cence imaging. Slices under these conditions were consid-
ered to be the control group. For experimental groups, the
medium was exchanged after the traumatising procedure with
experimental medium containing propofol (97% purity, Sigma
Aldrich, Munich, Germany) at concentrations between 10 and
400 M dissolved in 0.1% dimethyl sulfoxide (Roth, Karlsruhe,
Germany). The slices were incubated at temperatures of 37°C
or 32°C, for experiments under hypothermic conditions, for 72
hours before final fluorescence imaging.
Microscopy and staining
PI is a nucleic acid intercalating agent that is membrane-imper-
meable in vital cells with intact cell membranes. In damaged
cells gaps in the cell membrane allow PI to enter the cell form-
ing highly fluorescent complexes with nuclear DNA [7]. PI
intercalates in between the DNA double strands with little or
no base sequence preference with a stoichiometry of one dye
per four to five base pairs. The fluorescent PI/DNA complexes
have a peak emission in the red region of the visible light spec-
trum. After intercalation both the approximate fluorescence
excitation maximum and fluorescence emission maximum are
shifted to the right from 488 and 590 nm to 535 and 617 nm,
respectively.
Fluorescence images were taken with an upright fluorescence
microscope (Zeiss Axioplan, Carl Zeiss MicroImaging GmbH,
Jena, Germany) equipped with a rhodamine filter and a low-
power ×4 objective lens (Zeiss Achroplan 4×/0.10, Carl Zeiss
MicroImaging GmbH, Jena, Germany) and captured with a
digital camera (SPOT Pursuit 4 MP Slider, Diagnostic Instru-
ments Inc, Sterling Heights, MI, USA). Image acquisition soft-
ware (MetaVue, Molecular Devices, Sunnyvale, CA, USA) was
used for computer-based control of the microscope and to
capture the images from the digital camera. To compensate for
the changing intensity of the mercury lamp over time, reference
fluorescence measurements using a standard fluorescence
slide (Fluor-Ref, Omega Optical, Brattleboro, VT, USA) were
performed to adjust the exposure time accordingly prior to
every imaging session [3].
Injury quantification
The tissue injury in the slices was measured by pixel-based
image analysis. The images taken with the fluorescence micro-
scope were acquired as eight-bit monochrome images, thus
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every pixel's gray scale value was encoded with a resolution
ranging from 0 (black) to 255 (white). ImageJ (National Insti-
tutes of Health, Bethesda, MD, USA) was used to plot a gray
scale histogram for each image which shows the sum of all pix-
els sharing the same gray scale value from 0 to 255. Regions
with high gray scale values resembled damaged cells in the
images of traumatised slices with high PI uptake and high flu-
orescence light emission. Images of non-traumatised slices
showed a sharp, well-defined peak at gray scale values
between 20 and 75 (darker background coloured portions of
the image) falling rapidly to near zero at gray scale values of
over 75.
Using a series of control experiments a threshold of 75 was
established above which in non-traumatised slices just low
sums of pixels could be found. This method has been used in
previous publications [3,5,6]. The histograms of images from
traumatised slices showed a lower but broader background
signal peak which was slightly shifted to the right and a sec-
ond, well-defined peak at gray scale values between 160 and
180 (majority of highly fluorescent, damaged cells). The histo-
gram curve beyond a gray scale value of 75 was integrated.
The results yielded a profound, quantified measure of the PI
fluorescence and thus of the cell injury in the slices. The nor-
malised integral was defined as the trauma intensity. This anal-
ysis was performed for each slice in every group. Two types of
tissue injury were defined: 'Total injury' as the complete injury
over the slice and 'secondary injury' as the injury over slice
excluding the primary impact site of the stylus. For the calcula-
tion of the secondary injury we created a mask with the same
diameter as the stylus using ImageJ. The mask was positioned
exactly over the stylus' impact site in the images and excluded
this area from the pixel analysis and thus the calculation of the
trauma. The same mask was applied to every image when cal-
culating the secondary injury.
Statistical analysis
Throughout this article, the total and secondary injury are
expressed as fractions relative to the total injury observed after
72 hours under control conditions (37°C), which was normal-
ised to unity. For each experimental condition a mean number
of 17 slices was used (minimum number = 12, maximum
number = 26). The mean value and the standard error of the
mean (SEM) were calculated for the trauma intensities of the
slices in each group using SPSS software version 16.0
(SPSS Inc., Chicago, IL, USA). The test for statistical signifi-
cance was also performed with SPSS using an analysis of var-
iance (ANOVA). A P  0.05 was taken as statistically
significant.
Results
A very low level of tissue injury was maintained in all slices prior
to inclusion in the study groups. This initial injury could be
observed in all slices and is attributable to minimal cell death
originating from the preparation procedure and to influential
effects regarding the handling and maintenance of the slice
cultures over the 14-day cultivation time period. Yet the total
trauma signal in the baseline fluorescence measurement was
very low when compared with the maximum total trauma signal
observed after 72 hours in the trauma control group at 37°C
(0.004 ± 0.0004 vs. 1.00 ± 0.14; P = 0.00). The level of injury
was persistent over all slices with very little variation. This is
demonstrated by the data in Figure 1.
The next step was to identify the characteristics of traumatised
and non-traumatised slices with respect to their histograms in
order to establish a quantitative measurement tool to express
the extent of the tissue trauma. The comparison between trau-
matised and non-traumatised control group slices yielded very
different trauma signals in the fluorescence microscope image
histograms (Figure 2). The traumatised slices showed a
reduced peak in background signal between gray scale values
of 20 and 50 and a shift towards greater gray scale values with
a discrete peak at values between 160 and 180. Through
these control experiments a threshold was established at a
gray scale value of 75. Therefore, gray scale values greater
than 75 can be attributed to the traumatised tissue, which
became fluorescent due to PI uptake. The portion of the histo-
gram curves with a gray scale value greater than 75 were inte-
grated and the result used as a direct, quantitative figure for
the measurement of the extent of traumatic injury.
The trauma intensity increased steadily over time after trauma.
This is demonstrated by the data in Figure 3b in slices that
Figure 1
After 30 minutes of incubation with propidium iodide, baseline fluores-cence imaging was performed on all slices to qualify the l vel of cell injury prior to rauma
cence imaging was performed on all slices to qualify the level of cell 
injury prior to trauma. Histograms were computed from images by 
counting the sum of all pixels sharing the same eight-bit gray scale 
value (from 0 to 255). (a) The mean with the standard error of the mean 
(SEM) of a total of 206 slices included in this setting is shown. (b) An 
enlarged portion of the graph around the applied threshold of 75 
(dashed line) is shown. The continuous line is the mean value, and the 
dotted lines are the upper and lower bounds of the SEM. The data 
demonstrates the continuous low level of injury throughout the slices 
prior to traumatisation.
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were evaluated for trauma development using fluorescence
microscopy at 0 hours (0.006 ± 0.002), 24 hours (0.45 ±
0.05), 48 hours (0.69 ± 0.08) and 72 hours (1.00 ± 0.11)
post-traumatisation. This slow development of the injury
stands in contrast to the quickly achieved equilibrium state of
PI binding to the DNA in damaged cells, which has been
proven in previous publications [3], so the observed increase
in fluorescence over time can be attributed to the ongoing cell
death rather than to delayed PI uptake and fluorescence devel-
opment. The values in panel 3b were normalised against the
trauma intensity at t = 72 hours. The results of these control
experiments justify the sole measurement of the trauma after
72 hours and therefore we evaluated the tissue trauma only at
this time point.
Dimethyl sulfoxide (DMSO), the solving agent needed to solve
the lipophilic propofol in the aqueous medium, had no detect-
able effect on the total tissue trauma when administered. This
is demonstrated by the level of total trauma intensities in the
control group and the group treated with 0.1% DMSO (1.00
± 0.14 vs. 1.00 ± 0.09; Figure 3a). The comparison of the
trauma intensities between the trauma control group and the
non-traumatised group at 37°C yielded a significant difference
(1.00 ± 0.14 vs. 0.13 ± 0.04, P = 0.00), as expected.
Propofol at normothermia (37°C) was added to experimental
medium at concentrations of 10, 30, 50, 75, 100, 200 and
400 M. Figure 4a displays the concentration-response
curves for both the total (filled circles, upper curve) and sec-
ondary injury (open circles, lower curves). The nonlinear
regression curves were fitted into the graph to visualise the
trend. Figure 4b shows exemplary fluorescence images for
total and secondary injury (with applied mask for exclusion of
the stylus' direct impact site) in the trauma control group and
the group treated with 200 M propofol. A clearly visible
reduction of fluorescent, dead cells can be observed when
comparing the images of slices from each group, for total and
secondary injury. The total trauma intensities under normother-
mic conditions were 0.86 ± 0.13 (10 M), 0.73 ± 0.06 (30
M), 0.67 ± 0.08 (50 M), 0.42 ± 0.04 (75 M), 0.34 ± 0.05
(100 M), 0.07 ± 0.01 (200 M) and 0.08 ± 0.02 (400 M).
The secondary injury intensity in the control group under nor-
mothermic conditions was 0.43 ± 0.08. The intensities of the
observed secondary trauma with propofol treatment after
trauma under normothermic conditions were 0.29 ± 0.07 (10
M), 0.21 ± 0.05 (30 M), 0.25 ± 0.06 (50 M), 0.19 ± 0.02
(75 M), 0.08 ± 0.02 (100 M), 0.001 ± 0.0001 (200 M)
and 0.02 ± 0.003 (400 M).
Hypothermia at 32°C alone decreased the total tissue trauma
in this model by more than 50% (0.48 ± 0.10 vs. 1.00 ± 0.14,
P = 0.015), similar to previous reports [2-4]. A significant
reduction of total traumatic injury in hypothermia groups when
compared with the corresponding groups treated with the
same concentration of propofol under normothermic condi-
Figure 2
After preparation, cultivation for 14 days and baseline measurement, slices were either traumatised or not by the impact of a stylus onto he CA1 region of the hippocampus
slices were either traumatised or not by the impact of a stylus onto the 
CA1 region of the hippocampus. The extent of the trauma was evalu-
ated by fluorescence imaging 72 hours after the induced trauma and 
pixel-based image analysis. Curve a shows the histogram of non-trau-
matised slices (n = 17) at t = 72 hours. The straight line is the mean 
value, the dashed lines are the upper and lower bounds of the standard 
error of the mean. Curve b shows the histogram of traumatised slices (n 
= 17). For a better view of the important section the y-axis was split at 
12,000 and two different scales were used in both parts. The vertical 
dashed line is the applied threshold at a gray scale value of 75. The 
integral of all pixel values greater than the threshold was calculated for 
each group and defined as the trauma intensity. Two example images 
for (a) non-traumatised and (b) traumatised slices at t = 72 hours are 
shown in the upper right corner.
Figure 3
All groups were normalised against the trauma control group at t = 72 hours
hours. (a) No significant difference between the untreated traumatised 
control group and the group treated only with 0.1% dimethyl sulfoxide 
(DMSO) could be observed. The addition of 0.1% DMSO was neces-
sary to solve the lipophilic propofol in an aqueous medium. The 
detected trauma in the non-traumatised group and in the group with 
hypothermia was significantly lower compared with the trauma control 
group. * P  0.05. (b) The trauma intensity increased steadily over time, 
which has been shown before. This is demonstrated by slices (n = 14). 
Values were normalised against the trauma intensity at t = 72 hours.
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tions could be observed at propofol concentrations of 30 M
(0.37 ± 0.03 vs. 0.73 ± 0.06; P = 0.00) 50 M (0.34 ± 0.02
vs. 0.67 ± 0.08; P = 0.00) 75 M (0.14 ± 0.03 vs. 0.42 ±
0.04; P = 0.00) and 100 M (0.13 ± 0.02 vs. 0.34 ± 0.05; P
= 0.00), as shown in Figure 5. Thus, the use of mild hypother-
mia (32°C) in combination with propofol at concentrations
between 30 and 100 M showed a remarkable effect in reduc-
ing total tissue trauma. The trauma reduction between hypo-
thermia groups and the corresponding normothermia groups
ranged from 48.7% (30 M) to 66.4% (75 M) with a mean
reduction of 55.7%. The analysis using a two-way ANOVA
revealed a statistical significance (P < 0.0001) of both factors
(propofol concentrations and temperature) when applied inde-
pendently. The interaction, beyond the additive effect, of the
two factors was not statistically significant (P = 0.397).
In summary, post-traumatic administration of propofol led to a
dose-dependent decrease in total as well as secondary tissue
trauma, and the combination of propofol and hypothermia
were additive in regard to neuroprotection.
Discussion
We have investigated the potential beneficial neuroprotective
effects of propofol in an in vitro setting of TBI utilising the well-
established [2,3,5,6,8-17] model of organotypic hippocampal
slice cultures. We could show that propofol greatly diminishes
both total and secondary injury when administered in our in
vitro model of TBI. A dose-dependent neuroprotective effect
can be observed in the concentration range between 10 and
400 M propofol (Figure 4).
This method yields easy and open access to the nervous tis-
sue in vitro for manipulation and assessment. Yet, in contrast
to dissociated cell cultures, it retains most of the features of
tissue organisation as a heterogeneous population of cerebral
cells and functional characteristics, e.g. the preservation of
synaptic and anatomical organisation, with great similarities to
the in vivo state [2,8,11,13,14,16,18-21]. Hence, organotypic
hippocampal slice cultures are an appropriate compromise
between models using dissociated cell cultures and experi-
mental in vivo models with whole living animals [4,13,22,23].
The method of selectively traumatising the hippocampal slices
has been widely described and used before [3-6,22]. To a cer-
tain extent, it shares in vitro the characteristics of cerebral trau-
matic injury in vivo. We selectively traumatised the vulnerable
CA1 region of the hippocampus. The subsequent occurrence
of focal injury at the primary site of impact and the develop-
ment of secondary injury distant to that site are also compara-
ble with the in vivo situation. Thus, our model can be used as
a testing environment for experimental treatments with a suffi-
ciently high level of confidence.
The development of post-traumatic and post-ischaemic sec-
ondary injury has been analysed using this model in previous
studies [3,4]. A number of possible molecular and cellular
causes including the activation of pro-apoptotic mediator
pathways [24-26], up-regulation of cell death genes [12], free
radical generation, excitotoxicity [8] and cell-to-cell electrical
Figure 4
The extent of tissue trauma in the slices was quantified using pixel-based analysis of the cquired fluorescence im ges at t = 72 hours aft r tr uma
based analysis of the acquired fluorescence images at t = 72 hours 
after trauma. Total injury was defined as the total level of cell death in 
the slices. A minimum of 12 slices were evaluated per group. Second-
ary injury was calculated by covering the pin's direct impact site in the 
images with a defined mask excluding this area from trauma analysis. 
(a) The concentration-response curves of propofol from 10 to 400 M 
for both total (filled circles, upper curve) and secondary injury (open cir-
cles, lower curve). (b) Exemplary images for total and secondary injury 
(showing the impact site exclusion mask) in the control group and at a 
propofol concentration of 200 M. Non-linear regression curves were 
fitted into the graph to visualise the trends.
Figure 5
The use of hypothermia at a temperature of 32°C decreased the trauma int nsity
intensity. All groups were normalised against the trauma control group 
at 37°C. The black bars resemble the trauma intensity at normothermia 
(37°C) and propofol concentrations from 0 to 100 M after t = 72 
hours. The grey bars are the corresponding trauma intensities for slices 
treated with the same concentrations of propofol but kept at hypother-
mia (32°C) for 72 hours.
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communication possibly involving gap-junctions [21] have
been identified. In fact, observations have been made that sec-
ondary injury following TBI shares similarities with the post-
ischaemic neuronal damage observed in the penumbra sur-
rounding an ischaemic core following stroke [27]. This may
give rise to the assumption that similar neuroprotective strate-
gies may be successful in both aetiologies of brain injury.
PI was used in this method as a staining agent to assess the
degree of tissue injury. PI labelling has been proven to corre-
late well with the extent of neuronal injury [7,17,28] and used
as a cell viability marker in previous studies [3-5,9,14,17,29].
It is generally accepted that there is a linear correlation
between the cumulative fluorescence emission in PI-treated
tissue and the number of damaged cells when compared with
cell viability assessment relying on morphological criteria
[4,14,17].
The exact pharmacodynamic mechanism of action of propofol
is not fully known as yet. However, evidence indicates that it
primarily acts by potentiating the function of the gamma-ami-
nobutyric acid (GABA)A and possibly glycine-receptors [30-
32]. Additionally, recent results suggest that propofol may
interact with the endocannabinoid system [33,34], which
could contribute to its anaesthetic properties. Propofol has
previously been under investigation in both in vivo and in vitro
models of ischaemia-reperfusion injury and oxygen-glucose
deprivation. The in vitro studies have yielded both positive
[9,35-38] and negative [10,15,39] results for the neuroprotec-
tive benefits of propofol. In various in vivo studies a neuropro-
tective effect in terms of post-ischaemic cerebral damage
reduction could be demonstrated in models of transient [40-
44] but not permanent [45] focal ischaemia. The effects of
propofol in mechanical TBI have rarely been investigated to
date, although there is evidence that propofol can protect neu-
rons from acute mechanically induced cell death following
dendrotomy by potentiation of GABAA-receptor functions
[46].
Two in vivo studies in rodent models yielded negative results
concerning the neuroprotective effect of propofol [47,48]. The
results of these studies are in contrast to the findings pre-
sented in this study. This may be due to different circum-
stances found in experimental models using whole living
animals with all present systemic variables, which are absent
in our model of TBI. In addition, the six-hour period of post-
traumatic propofol application until the final assessment of
brain injury was significantly shorter than the three-day period
used in our model. There is also a difference in the propofol
concentrations used and the point of application, which is
beyond the blood-brain barrier in our study. Recent studies
have focused on the concentrations of propofol in the blood
serum, cerebrospinal fluid and brain parenchyma and found
that when propofol is administered directly via the nutrient
medium in a model of organotypic brain slices a final equilib-
rium concentration of propofol in the brain parenchyma is not
reached until 360 minutes after the start of propofol adminis-
tration [49].
Hypothermia at 32°C alone had a strong effect in reducing the
trauma intensity by more than 50% (Figure 3). These results
are not entirely surprising because the neuroprotective benefit
of hypothermia has been demonstrated before [2-4,50]. When
hypothermia was combined with propofol at concentrations
between 30 and 100 M, a further reduction in total traumatic
injury could be achieved (Figure 5).
There are several issues in this study that must be clarified.
First, the maximum clinically feasible propofol concentration in
the cerebral tissue remains unclear. Some authors consider
the concentrations used in this study (10 to 400 M) to be rea-
sonable [9,10,51-54], whereas they are considered to be too
high by others [49,55,56]. Second, the hippocampal slice cul-
ture model, besides its many favourable advantages, bears
certain disadvantages that need to be mentioned. Due to the
nature of the model it excludes mechanisms of injury that may
influence brain damage in the in vivo situation such as the
absence of any injury pathways related or due to brain swelling
inside an enclosed skull, reperfusion injury, global or local
ischaemia and/or hypoxia and other systemic variables. Third,
propofol was administered directly following the traumatisa-
tion procedure excluding the effects of a delay possibly
encountered in clinical routine management of patients with
TBI.
When interpreting our results with attention towards the scien-
tific value and its importance for possible future medical appli-
cation one should consider the positive findings made are
based on a simplified in vitro model of TBI similar but still dis-
tant from the situation in the patients seen and treated every
day. Still, our results possibly contribute to the development of
alternative treatment options for TBI and encourage further
research in that field, preferably in studies involving whole liv-
ing animals.
Conclusions
In this study we could show that propofol is an effective neu-
roprotective agent when administered after TBI in the hippoc-
ampal slice culture model. Propofol reduced both the total
tissue injury as well as the secondary injury distant to the pri-
mary site of brain injury. This effect was dose-dependent and
increased up to 400 M, the greatest concentration of propo-
fol that was tested. Hypothermia at 32°C alone reduced the
tissue injury by about factor two. When hypothermia and pro-
pofol were combined a cumulative effect could be observed
and the extent of brain injury was further reduced throughout
all concentrations that underwent investigation.
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